CHO Pharma, Inc. (TPEX:6586)
Taiwan · Delayed Price · Currency is TWD 110.50
-1.50 (-1.34%)
Aug 26, 2026, 1:37 PM CST
CHO Pharma Market Cap
CHO Pharma has a market cap or net worth of 23.97 billion as of August 25, 2026. Its market cap has increased by 180.00% in one year.
Market Cap
23.97B
Enterprise Value
22.02B
Revenue
1.71M
Ranking
n/a
PE Ratio
n/a
Stock Price
110.50
ChartMarket Cap Chart
Since September 27, 2017, CHO Pharma's market cap has increased from 15.00B to 23.97B, an increase of 59.80%. That is a compound annual growth rate of 5.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2026 | 23.97B | 298.58% |
| Dec 31, 2025 | 6.01B | -45.44% |
| Dec 31, 2024 | 11.02B | -25.68% |
| Dec 29, 2023 | 14.83B | -41.16% |
| Dec 30, 2022 | 25.20B | 64.15% |
| Dec 30, 2021 | 15.35B | 235.65% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 27, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Oneness Biotech | 22.82B |
| Sunmax Biotechnology | 21.84B |
| Medigen Vaccine Biologics | 18.25B |
| TaiMed Biologics | 17.40B |
| Ever Supreme Bio Technology | 16.49B |
| EirGenix | 15.23B |
| Gongwin Biopharm Holdings | 13.45B |
| ACRO Biomedical | 13.21B |